AU7257101A - Influenza virus binding, sialylated oligosaccharide substance and use thereof - Google Patents

Influenza virus binding, sialylated oligosaccharide substance and use thereof

Info

Publication number
AU7257101A
AU7257101A AU72571/01A AU7257101A AU7257101A AU 7257101 A AU7257101 A AU 7257101A AU 72571/01 A AU72571/01 A AU 72571/01A AU 7257101 A AU7257101 A AU 7257101A AU 7257101 A AU7257101 A AU 7257101A
Authority
AU
Australia
Prior art keywords
influenza virus
virus binding
sialylated oligosaccharide
oligosaccharide substance
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72571/01A
Other languages
English (en)
Inventor
Karl-Anders Karlsson
Halina Miller-Podraza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotie Therapies Corp
Original Assignee
Carbion Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carbion Oy filed Critical Carbion Oy
Publication of AU7257101A publication Critical patent/AU7257101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU72571/01A 2000-06-21 2001-06-20 Influenza virus binding, sialylated oligosaccharide substance and use thereof Abandoned AU7257101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20001477A FI20001477A7 (fi) 2000-06-21 2000-06-21 Influenssavirusta sitova aine ja sen käyttö
FI20001477 2000-06-21
PCT/FI2001/000587 WO2001097819A1 (en) 2000-06-21 2001-06-20 Influenza virus binding, sialylated oligosaccharide substance and use thereof

Publications (1)

Publication Number Publication Date
AU7257101A true AU7257101A (en) 2002-01-02

Family

ID=8558611

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72571/01A Abandoned AU7257101A (en) 2000-06-21 2001-06-20 Influenza virus binding, sialylated oligosaccharide substance and use thereof

Country Status (6)

Country Link
US (1) US7902170B2 (enExample)
EP (1) EP1320374A1 (enExample)
JP (1) JP2003535965A (enExample)
AU (1) AU7257101A (enExample)
FI (1) FI20001477A7 (enExample)
WO (1) WO2001097819A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20031536A0 (fi) * 2003-10-20 2003-10-20 Biotie Therapies Oyj Korkean affiniteetin ligandit influenssavirukselle ja menetelmät niiden valmistamiseen
WO2006025443A1 (ja) 2004-08-31 2006-03-09 National Institute Of Advanced Industrial Scienceand Technology ラクトシルセラミドを生産する遺伝子組換え植物、およびその利用
JP2006288210A (ja) 2005-04-05 2006-10-26 National Institute Of Advanced Industrial & Technology 糖転移酵素遺伝子の導入による生体内糖鎖伸長の技術
FI20060200A0 (fi) * 2005-04-20 2006-02-27 Glykos Finland Oy Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi
WO2007026669A1 (ja) * 2005-09-02 2007-03-08 Shizuoka Prefectural Universities Corporation ウイルスレセプター糖鎖認識特異性の判別方法
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
US20250302865A1 (en) * 2022-03-16 2025-10-02 Pharmalectin, Inc. Lectin-binding carbohydrates for treating viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0508493A1 (en) * 1986-08-06 1992-10-14 Mect Corporation Ganglioside related compounds and method of producing the same
US5254676A (en) * 1991-11-22 1993-10-19 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
US5220008A (en) * 1991-11-22 1993-06-15 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
CA2261877C (en) * 1996-07-23 2009-04-07 Seikagaku Corporation Novel lactosamine oligosaccharide and method for producing the same

Also Published As

Publication number Publication date
JP2003535965A (ja) 2003-12-02
US7902170B2 (en) 2011-03-08
FI20001477L (fi) 2001-12-22
FI20001477A7 (fi) 2001-12-22
FI20001477A0 (fi) 2000-06-21
WO2001097819A1 (en) 2001-12-27
US20030181714A1 (en) 2003-09-25
EP1320374A1 (en) 2003-06-25

Similar Documents

Publication Publication Date Title
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU7429100A (en) Chondrocyte compositions, preparation and use thereof
AU2001248279A1 (en) New compounds, their preparation and use
ZA200007299B (en) Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol.
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
AU3148399A (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
IL147436A0 (en) Respiratory syncytial viruses expressing immune modulatory molecules
ZA996814B (en) Aluminosilicate compositions, preparation and use.
ZA200200222B (en) Titanium derived compounds, preparation and use thereof.
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU4996100A (en) (s,r) formoterol methods and compositions
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
AU2001289831A1 (en) Medicaments against viral infections
AU7257101A (en) Influenza virus binding, sialylated oligosaccharide substance and use thereof
AU3971500A (en) Indazole derivatives, preparation and therapeutic application thereof
AU2001278337A1 (en) Respiratory syncytial virus vaccine
HUP0300330A3 (en) Oligosaccharides, pharmaceutical compositions containing them and preparation thereof
AU2002304146A1 (en) Adhesive substance, adhesive product, and connected structure
AU2401601A (en) Check valve, and syringe using the same
IL165779A0 (en) Steroid conjugate, preparation thereof and the usethereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
MXPA03006162A (es) Derivados de mikanolida, su preparacion y sus usos terapeuticos.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase